Exercise Prescription for Established Cardiovascular Disease

Why Exercise Matters After a Cardiovascular Event

Exercise-based cardiac rehabilitation is one of the most cost-effective interventions available for secondary prevention in heart disease. A 2021 Cochrane systematic review of 85 trials involving 23,430 participants with coronary heart disease found that exercise-based cardiac rehab reduced cardiovascular mortality by 26% (risk ratio 0.74 to 95% CI 0.64 to 0.86) and hospital admissions by 44% compared to usual care [1]. These numbers represent lives saved, not marginal statistical effects.

The mechanism is multifactorial. Regular aerobic exercise improves endothelial function, reduces systemic inflammation (measured by high-sensitivity C-reactive protein reductions of 15-30%), lowers resting blood pressure by an average of 5-7 mmHg systolic, and improves autonomic tone, shifting the sympathovagal balance toward parasympathetic predominance [9]. In patients with heart failure and reduced ejection fraction, the HF-ACTION trial (N=2,331) demonstrated that structured exercise training improved 6-minute walk distance and self-reported health status, with an adjusted 11% reduction in all-cause mortality or hospitalization (HR 0.89 to 95% CI 0.81 to 0.99) [10].

The European Society of Cardiology (ESC) 2024 guidelines on chronic coronary syndromes assign exercise-based cardiac rehabilitation a Class I, Level A recommendation [2]. The American Heart Association echoes this, calling it "a guideline-directed therapy" in its 2019 performance measures for cardiac rehabilitation referral [8].

Phases of Cardiac Rehabilitation

Cardiac rehabilitation follows a structured three-phase model. Each phase builds on the last, progressing from supervised hospital-based activity to independent lifelong exercise.

Phase I (Inpatient). This begins during hospitalization. Low-level mobilization (walking in the corridor, seated range-of-motion exercises) starts within 24-48 hours of an uncomplicated MI or percutaneous coronary intervention. The goal is to prevent deconditioning and deep vein thrombosis, not to build fitness. Patients should be able to walk 200 meters on a flat surface before discharge [8].

Phase II (Outpatient Supervised). This is the core of cardiac rehab. It typically runs 12 weeks (36 sessions) and includes ECG-monitored exercise, risk factor education, and psychosocial support. Patients exercise at 40-80% of heart rate reserve (Karvonen method) or at an RPE of 11-14 on the Borg scale. The AHA and AACVPR recommend that Phase II programs include both aerobic and resistance training components [3].

Phase III (Maintenance). Long-term, community-based or home-based exercise. Patients follow individualized programs designed during Phase II. Monitoring requirements decrease, but periodic reassessment of exercise capacity (via cardiopulmonary exercise testing or 6-minute walk test) helps adjust prescriptions [11].

A significant problem exists: fewer than one in four eligible patients complete Phase II. The CDC reports that only 24.4% of MI survivors and 13.9% of coronary artery bypass graft patients participate in cardiac rehab [4]. Women, older adults, racial minorities, and rural populations are disproportionately underserved. Home-based programs with remote monitoring may help close this gap. The BRUM-HF trial showed that a home-based program produced exercise capacity improvements comparable to center-based rehab at 12 months [12].

Aerobic Exercise Protocol

The aerobic prescription for established CVD follows a frequency, intensity, time, and type (FITT) framework. The target is 150 minutes per week of moderate-intensity exercise or 75 minutes of vigorous-intensity exercise, consistent across AHA, ESC, and WHO guidelines [2][8].

Frequency. Three to five sessions per week. Daily activity is ideal, but three supervised sessions plus two unsupervised sessions is a practical starting point.

Intensity. Moderate intensity corresponds to 40-59% of VO2 reserve, 64-76% of maximum heart rate, or Borg RPE 12-13. Vigorous intensity is 60-85% of VO2 reserve. In beta-blocked patients, heart rate targets require adjustment using the Karvonen formula applied to the medicated maximum heart rate from a graded exercise test, since resting and maximal heart rates are both blunted [3]. RPE becomes especially useful here.

Time. Sessions of 30-60 minutes, including warm-up and cool-down. Patients early in Phase II may tolerate only 10-15 minute bouts, which can be accumulated across the day.

Type. Walking remains the most accessible modality. Cycling, rowing, and elliptical training are alternatives that reduce orthopedic stress. Swimming may be introduced once sternal wounds (post-CABG) are fully healed, typically at 8-12 weeks.

For high-intensity interval training (HIIT), the evidence is increasingly favorable. The Norwegian SMARTEX trial and the HIT or MISS trial (N=261) both compared HIIT (4x4 minutes at 85-95% of peak heart rate, separated by 3-minute active recovery periods) to moderate continuous training in post-MI patients [6]. VO2peak improvements were similar between groups (approximately 10% increase), but HIIT achieved this in less total exercise time. The 2019 European Association of Preventive Cardiology position statement endorsed HIIT as an option in stable, risk-stratified patients who have completed at least 4 weeks of moderate-intensity training [13].

Resistance Training Guidelines

Resistance training was historically avoided in cardiac patients due to concerns about blood pressure spikes and ventricular remodeling. That caution has given way to evidence. The AHA published a scientific advisory in 2007 (reaffirmed in subsequent guidelines) endorsing resistance training as safe and beneficial in stable cardiac patients [3].

The prescription: two non-consecutive days per week, 8-10 exercises targeting major muscle groups, 1-3 sets of 10-15 repetitions at 40-60% of one-repetition maximum. Patients should avoid the Valsalva maneuver, breathe continuously (exhale on exertion), and stop if they experience chest pain, dizziness, or excessive dyspnea. Free weights and machines are both acceptable. Elastic bands and bodyweight exercises may be preferable for early-phase or elderly patients.

Resistance training produces benefits that aerobic exercise alone does not fully address. These include preservation of lean muscle mass (critical in patients with cardiac cachexia), improved insulin sensitivity, reduced fall risk, and better performance of daily tasks like carrying groceries or climbing stairs [14]. The PARIS-3D study found that combined aerobic and resistance training improved peak VO2 by 16.3% vs. 9.8% with aerobic training alone in heart failure patients [15].

One precaution specific to post-sternotomy patients: upper-body resistance exercises should be deferred until 8-12 weeks post-CABG to allow sternal healing. Lower-body exercises can begin earlier with physician clearance.

Exercise Prescription for Peripheral Arterial Disease

PAD affects approximately 8.5 million Americans and presents a distinct exercise challenge: intermittent claudication limits walking tolerance. Yet walking is the treatment. The irony is intentional.

Supervised exercise therapy (SET) is a Class I recommendation from the AHA/ACC for symptomatic PAD [16]. The Cochrane review of supervised exercise for intermittent claudication (32 trials, 1,835 participants) reported that SET improved maximal walking distance by a mean of 82 meters compared to usual care [7]. That gain exceeds the improvement seen with cilostazol (the only FDA-approved drug for claudication), which adds roughly 50 meters.

The standard SET protocol involves treadmill walking at a speed and grade that induces moderate claudication pain (3-4 on a 5-point pain scale) within 3-5 minutes, followed by rest until pain resolves, then repeated. Sessions last 30-60 minutes total (including rest periods), three times per week, for a minimum of 12 weeks. The CLEVER trial (N=111) demonstrated that SET was superior to stenting plus optimal medical therapy for improving treadmill walking performance at 6 months, though stenting provided better quality-of-life scores [17].

Home-based walking programs are an alternative when SET is unavailable. The GOALS trial (N=194) showed that a structured home-based walking program with behavioral coaching improved 6-minute walk distance by 53.5 meters vs. 6.0 meters in the health education control group at 12 months [18].

Post-Stroke Exercise Considerations

Stroke survivors face compounding barriers: hemiparesis, spasticity, balance deficits, fatigue, and depression. Physical activity levels after stroke drop to approximately one-third of pre-stroke levels [19]. The AHA/ASA scientific statement on physical activity after stroke recommends aerobic exercise (20-60 minutes, 3-5 days per week at 40-70% heart rate reserve) starting in the subacute phase, combined with task-specific functional training [19].

Body-weight-supported treadmill training, recumbent cycling, and aquatic exercise are modalities adapted for neurological deficits. The LEAPS trial (N=408) found that locomotor training initiated 2 months post-stroke produced equivalent functional walking outcomes compared to a structured home exercise program at 12 months [20]. The key variable was exercise dose, not setting.

For stroke patients with concurrent coronary artery disease (common, given shared risk factors), dual-purpose cardiac and neurological rehabilitation programs save time and improve adherence. Blood pressure monitoring during exercise is especially important: exercise-induced hypertension (>250/115 mmHg) is an absolute contraindication to continued exertion.

Role of Pharmacotherapy Alongside Exercise

Exercise and pharmacotherapy are not competing strategies. They work through overlapping and complementary pathways. The SELECT trial (N=17,604) randomized adults with established atherosclerotic CVD and BMI of 27 or higher (without diabetes) to semaglutide 2.4 mg weekly or placebo [5]. At a mean follow-up of 39.8 months, semaglutide reduced the composite MACE endpoint (cardiovascular death, non-fatal MI, or non-fatal stroke) by 20% (HR 0.80 to 95% CI 0.72 to 0.90, P<0.001). Mean body weight loss was 9.39% vs. 0.88% with placebo.

"These results extend the cardiovascular benefits of semaglutide to a broad population with established atherosclerotic disease, independent of diabetes status," wrote A. Michael Lincoff, MD, the trial's principal investigator, in the New England Journal of Medicine [5].

GLP-1 receptor agonists may also improve exercise tolerance indirectly by reducing body weight, lowering blood pressure (mean reduction of 3.4 mmHg systolic in SELECT), and decreasing systemic inflammation [5]. For patients with established CVD who carry excess weight, combining structured exercise with GLP-1 therapy addresses both the fitness deficit and the metabolic burden.

Statins remain the bedrock of secondary prevention pharmacotherapy. The Cholesterol Treatment Trialists meta-analysis of 170,000 participants demonstrated that each 1 mmol/L reduction in LDL cholesterol decreased major vascular events by 22% [21]. Exercise does not replace statin therapy. It adds an independent mortality benefit on top of it.

Safety, Monitoring, and When to Stop

Exercise in established CVD is safe when properly prescribed and monitored. Cardiac arrest during supervised rehab occurs at a rate of approximately 1 per 116,906 patient-hours, with a survival rate exceeding 95% in programs with trained staff and defibrillators on-site [22].

Risk stratification before exercise follows AACVPR criteria, dividing patients into low, moderate, and high risk based on left ventricular ejection fraction, exercise capacity, presence of ischemia, and arrhythmia burden [3]. High-risk patients (LVEF <40%, complex ventricular arrhythmias, exercise-induced ischemia at low workloads) require ECG monitoring during all exercise sessions and a lower intensity ceiling.

Absolute contraindications to exercise include unstable angina, decompensated heart failure, uncontrolled arrhythmias, severe aortic stenosis (mean gradient >40 mmHg), acute myocarditis or pericarditis, and acute aortic dissection [2]. Relative contraindications include uncontrolled hypertension (>180/110 mmHg at rest), high-degree AV block, and recent embolism.

"Cardiac rehabilitation is one of the most underutilized, evidence-based treatments in cardiovascular medicine," wrote Randal Thomas, MD, MS, in the Journal of the American College of Cardiology [23]. Thomas and colleagues proposed that rehab referral be treated as a performance measure, equivalent in importance to prescribing aspirin or a statin at discharge.

The session-level protocol for stopping exercise: chest discomfort, new or worsening dyspnea disproportionate to effort, dizziness, heart rate exceeding 20 bpm above target, ST-segment depression of 2 mm or greater on telemetry, or systolic blood pressure drop of 10 mmHg or more with increasing workload. Any of these warrants immediate cessation and physician evaluation.